Biotechnology News

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of...

WILMINGTON, Del., Oct. 29, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, “NRx” or “the Company”), a clinical-stage biopharmaceutical company developing therapeutics based on its...

Company to Host Conference Call with Live Q&A, November 12, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – October 29, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH), a leading precision...

OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung

Résultats finaux positifs pour le critère principal et plusieurs critères secondaires présentés par le Pr Federico Cappuzzo, PhD, le 25 octobre 2026 au congrès annuel de l’European Society for Medical...

Selection recognizes scientific progress and commercial potential while expanding visibility among institutional investors and pharmaceutical partners

20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy

Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, Oct. 29, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage...

Nonclinical studies demonstrated reductions in two key measures of neuropathic pain Ongoing Phase 2 CAReS trial includes pain endpoints to evaluate ART27.13's potential to address multiple...

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Today Precision Neuroscience Corporation (Precision), a leader in minimally invasive brain–computer interface (BCI) technology, announced the first...